The Argument for Oversight

  1. Home
  2. Research & Impact
  3. Publications
  4. The Argument for Oversight
Back to All Publications
The fundamental problem of managing biotechnology arises from two circumstances. First, it is evident that the momentum of discovery in molecular biology in particular is simultaneously enabling therapeutic and destructive applications of extraordinary potential consequence. But, second, no one is able to judge with assurance the exact character or extent of those consequences. That situation is likely to require competent but independent oversight of those areas of research that inherently pose extreme danger. An outline of an appropriate oversight arrangement will be presented.

Related Publications

View All Publications
Impacts of EPA’s finalized power plant greenhouse gas standards

School Authors: Allen Fawcett, Gokul Iyer, Alicia Zhao

Other Authors: John Bistline, Aaron Bergman, Geoffrey Blanford, Maxwell Brown, Dallas Burtraw, Maya Domeshek, Anne Hamilton, Jesse Jenkins, Ben King, Hannah Kolus, Amanda Levin, Qian Luo, Kevin Rennert, Molly Robertson, Nicholas Roy, Ethan Russell, Daniel Shawhan, Daniel Steinberg, Anna van Brummen, Grace Van Horn, Aranya Venkatesh, John Weyant, Ryan Wiser